Akcije

Scripta Medica
kako citirati ovaj članak
podeli ovaj članak

Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:7
  • preuzimanja u poslednjih 30 dana:5

Sadržaj

članak: 6 od 7  
Back povratak na rezultate
2013, vol. 44, br. 2, str. 75-78
C-reactive protein and fibrinogen in type 2 diabetes mellitus
(naslov ne postoji na srpskom)
aUniverzitet u Sarajevu, Medicinski fakultet, Federacija BiH
bKlinički centar Univerziteta Sarajevo, Federacija BiH
cCantonal Hospital Zenica, Department of Laboratory Diagnostics
dCantonal Hospital Zenica, Department of Internal Diseases

e-adresasabaheta.hasic@mf.unsa.ba
Sažetak
(ne postoji na srpskom)
Introduction. Chronic,low-grade inflammation is important in the development and progression of type 2 diabetes mellitus (T2DM). Indicators of increased inflammatory activity include elevated values of circulating acute phase proteins like C-reactive protein (CRP) and fibrinogen. The aim of the study was to test sex-related differences in CRP and fibrinogen blood levels in T2DM patients. Patients and Methods. The cross-sectional study included 40 T2DM patients, both sexes (19 males and 21 females), median age 70 (36-90) years. Patients were hospitalized at the Clinic of Endocrinology, Clinical Center University of Sarajevo. The fasting glucose levels, glycated haemoglobin, fibrinogen and CRP in the blood of T2DM patients were determined by standard laboratory methods. The data were analysed by statistical software SPSS 19. Results. The median values of CRP and fibrinogen in blood were not statistically different between female and male T2DM patients, although values had tendency to be higher in female patients [17.30 mg/L (3.40-61.35) vs. 9.60 mg/L (3.50-28.90); p=0.573]; [5.70 g/L (4.20-6.35) vs. 3.80 g/L (3.60-6.00); p=0.078]. A positive correlation between CRP and fibrinogen was found in samples from female T2DM patients (rho=0.606;p<0.01). Conclusion. Elevated CRP and fibrinogen indicate the presence of inflammation in T2DM patients. Female patients had higher values of both inflammatory markers in blood in comparison to males, but we did not prove statistically significant sex-related differences.
Reference
Ahonen, T., Saltevo, J., Laakso, M., Kautiainen, H., Kumpusalo, E., Vanhala, M. (2009) Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure. Mediators of Inflammation, 2009: 1-6
Alzahrani, S.H., Hess, K., Price, J.F., Strachan, M., Baxter, P.D., Cubbon, R., Phoenix, F., Gamlen, T., Ariëns, R.A.S., Grant, P.J., Ajjan, R.A. (2012) Gender-specific alterations in fibrin structure function in type 2 diabetes: Associations with cardiometabolic and vascular markers. Journal of Clinical Endocrinology & Metabolism, 97(12): E2282-E2287
Badawi, A., Klip, A., Haddad, P., Cole, D.E.C., Bailo, G.B., El-Sohemy, A., et al. (2010) Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3: 173-186
Blake, G.J., Ridker, P.M. (2002) Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine, 252(4): 283-294
Bosevski, M., Bosevska, G., Stojanovska, L. (2013) Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: A preliminary report. Cardiovascular Diabetology, 12(1): 29-29
Cartier, A., Côté, M., Lemieux, I., Pérusse, L., Tremblay, A., Bouchard, C., Després, J. (2009) Sex differences in inflammatory markers: What is the contribution of visceral adiposity?. American Journal of Clinical Nutrition, 89(5): 1307-1314
Festa, A., D'agostino, R. J., Howard, G., Mykkänen, L., Tracy, R.P., Haffner, S.M. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 102(1): 42-7
Ilić, D., Pešić, M., Savić, T., Stanković, N., Đinđić, B. (2008) Gender-related differences in inflammatory and lipid parameters in patients with diabetes mellitus type 2. Acta medica Medianae, vol. 47, br. 3, str. 39-43
Jain, A., Gupta, H.L., Narayan, S. (2001) Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate. J Assoc Physicians India, 49: 227-230
Khera, A., McGuire, D.K., Murphy, S.A., Stanek, H.G., Das, S.R., Vongpatanasin, W., Wians, F.H., Grundy, S.M., de Lemos, J.A. (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol, 46(3): 464-9
Kwok, S., Canoy, D., Ashton, W.D., Lowe, G.D.O., Wood, D., Humphries, S.E., Charlton-Menys, V., Durrington, P.N. (2009) Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: The United Kingdom Women's Heart Study (UKWHS). Clinical Endocrinology (Oxf), 71(5): 727-732
Laakso, M. (2010) Cardiovascular disease in type 2 diabetes from population to man to mechanisms: The Kelly West Award Lecture 2008. Diabetes Care, 33(2): 442-449
Lai, M.M., Li, C.I., Kardia, S.L.R., Liu, C., Lin, W., Lee, Y., Chang, P., Lin, C., Tsai-Chung, L. (2010) Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health, 10(1): 429-429
Lakoski, S.G., Cushman, M., Criqui, M., Rundek, T., Blumenthal, R.S., D'agostino, R.B., Herrington, D.M. (2006) Gender and C-reactive protein: Data from the multiethnic study of atherosclerosis (MESA) cohort. American Heart Journal, 152(3): 593-598
Maritim, A.C., Sanders, R.A., Watkins, J.B. (2003) Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical and Molecular Toxicology, 17(1): 24-38
Pasceri, V., Willerson, J.T., Yeh, E.T.H. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102(18): 2165-2168
Qasim, A.N., Budharaju, V., Mehta, N.N., St, C.C., Farouk, S., Braunstein, S., Schutta, M., Iqbal, N., Rader, D.J., Reilly, M.P. (2011) Gender differences in the association of C-reactive protein with coronary artery calcium in Type-2 diabetes. Clinical Endocrinology (Oxf), 74(1): 44-50
Stec, J.J., Silbershatz, H., Tofler, G.H., Matheney, T.H., Sutherland, P., Lipinska, I., Massaro, J.M., Wilson, P.F.W., Muller, J.E., D'agostino, R.B. (2000) Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation, 102(14): 1634-1638
Torzewski, J., Torzewski, M., Bowyer, D.E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., Hombach, V. (1998) C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(9): 1386-1392
Vanninen, E., Laitinen, J., Uusitupa, M. (1994) Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care, 17(9): 1031-1038
Verma, S., Kuliszewski, M., Li, S., et al. (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation, 109: 2058-67
Zwaka, T.P., Hombach, V., Torzewski, J. (2001) C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation, 103(9): 1194-1197
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.5937/scriptamed1302075H
objavljen u SCIndeksu: 10.10.2019.